Nivalis Therapeutics
is developing a novel class of disease modifying therapies that are designed to preserve intracellular S-nitrosoglutathione... Read moreNivalis Therapeutics
is developing a novel class of disease modifying therapies that are designed to preserve intracellular S-nitrosoglutathione... Read more
CEO
Add
News
Apr 06, 2026
Citybizlist
Nivalis Therapeutics: Avalyn Appoints Jon Congleton To Board
Nov 02, 2018
BioPortfolio
Nivalis Therapeutics: Nivalis Therapeutics Inc NVLS Pharmaceuticals Healthcare Deals and Alliances Profile Report Updated 27092018 Prices from USD $250
Jul 27, 2018
BioPortfolio
Nivalis Therapeutics: Nivalis Therapeutics Inc NVLS Pharmaceuticals Healthcare Deals and Alliances Profile Report Updated 23042018 Prices from USD $250
Mar 24, 2018
BioPortfolio
Nivalis Therapeutics: Nivalis Therapeutics Inc NVLS Pharmaceuticals Healthcare Deals and Alliances Profile Report Updated 13032018 Prices from USD $250
Dec 06, 2017
BioPortfolio
Nivalis Therapeutics: Nivalis Therapeutics Inc NVLS Pharmaceuticals Healthcare Deals and Alliances Profile Report Updated 14112017 Prices from USD $250
Nov 29, 2017
BioPortfolio
Nivalis Therapeutics: Nivalis Therapeutics Inc NVLS Financial and Strategic SWOT Analysis Review Report Updated 13112017 Prices from USD $300
Oct 12, 2017
BioPortfolio
Nivalis Therapeutics: Nivalis Therapeutics Inc NVLS Pharmaceuticals Healthcare Deals and Alliances Profile Report Updated 17082017 Prices from USD $250
Aug 10, 2017
4-traders
Nivalis Therapeutics: Nivalis Therapeutics : Patent Issued for Chromone Inhibitors of S-Nitrosoglutathione Reductase (USPTO 9717706)
Aug 09, 2017
BioPortfolio
Nivalis Therapeutics: Nivalis Therapeutics Inc NVLS Financial and Strategic SWOT Analysis Review Report Updated 07082017 Prices from USD $300
Jul 27, 2017
OTC Breaking News
Nivalis Therapeutics: Corporate News Blog - Alpine Immune Sciences Goes Public on NASDAQ; Announces the Completion of an Immuno-Oncology Merger with Nivalis Therapeutics
Nivalis Therapeutics Competitors
1
2
3
4
5
6
7
8
9
10